Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Pediatric Gastroenterology, Hepatology & Nutrition ; : 366-376, 2020.
Article | WPRIM | ID: wpr-834127

ABSTRACT

Purpose@#To assess the association between birth weight and the development of functional gastrointestinal disorders (FGIDs) in the first year of life. @*Methods@#This is a secondary analysis of a prospective cohort multicenter study including neonates, consecutively enrolled at birth, and followed up for one year. At birth all infants were classified by birth weight as extremely low (ELBW), very low, or low when 90th percentile) for gestational age. FGIDs were classified according to the Rome III criteria and assessed at 1, 3, 6, and 12 months of life. @*Results@#Among 1,152 newborns enrolled, 934 (81.1%) completed the study: 302 (32.3%) were preterm, 35 (3.7%) were ELBW, 104 (11.1%) were SGA, 782 (83.7%) were AGA, and 48 (5.1%) were LGA infants. Overall, throughout the first year of life, 718 (76.9%) reported at least one FGID. The proportion of infants presenting with at least one FGID was significantly higher in ELBW (97%) compared to LBW (74%) (p=0.01) and in LGA (85.4%) and SGA (85.6%) compared to AGA (75.2%) (p=0.0001). On multivariate analysis, SGA was significantly associated with infantile colic. @*Conclusion@#We observed an increased risk of FGIDs in ELBW, SGA, and LGA neonates. Our results suggest that prenatal factors determining birth weight may influence the development of FGIDs in infants. Understanding the role of all potential risk factors may provide new insights and targeted approaches for FGIDs.

2.
Pediatric Gastroenterology, Hepatology & Nutrition ; : 35-48, 2020.
Article in English | WPRIM | ID: wpr-782186

ABSTRACT

6 years (RR=4.15), with previous abdominal pain (RR=7.2) or constipation (RR=4.06). Constipation was recorded in 23/289 (8.0%), with increased risk in children having surgery (RR=2.56) or previous constipation (RR=7.38). Probiotic supplementation significantly reduced AAD (RR=0.30) and abdominal pain (RR=0.36). Lactobacillus rhamnosus GG (LGG) and L. reuteri significantly reduced AAD (RR=0.37 and 0.35) and abdominal pain (RR=0.37 and 0.24).CONCLUSION: AAD occurred in 20.4% of children, with increased risk at younger age, lower respiratory and urinary tract infections, intravenous treatment and previous AAD. LGG and L. reuteri reduced both AAD and associated abdominal pain.


Subject(s)
Child , Humans , Abdominal Pain , Administration, Intravenous , Anti-Bacterial Agents , Constipation , Diarrhea , Incidence , Inpatients , Limosilactobacillus reuteri , Lacticaseibacillus rhamnosus , Probiotics , Prospective Studies , Protective Factors , Urinary Tract Infections
SELECTION OF CITATIONS
SEARCH DETAIL